Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cancer chemoprevention from the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazol[4,5-b]pyridine: reconsideration of the evidence.

Mutation research - 28 Nov 1997

Paolini M, Biagi G L, Cantelli-Forti G

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticarcinogenic Agents
Share to Cytochrome P-450 CYP1A2
Share to Diterpenes
Share to Hydroxylation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Inactivation, Metabolic

Share to Microsomes, Liver

Share to Phytotherapy

Source

Identifiers

PMID: 9434884
DOI: 10.1016/s0027-5107(97)00220-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer chemoprevention from the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazol[4,5-b]pyridine: reconsideration of the evidence.PMID 9434884Read ↗

Food and cancer prevention.Semantic proximity Read ↗

Food-Borne Chemical Carcinogens and the Evidence for Human Cancer RiskSemantic proximity Read ↗

Preventable Exposures Associated With Human CancersSemantic proximity Read ↗

Advances in cancer epidemiology: understanding causal mechanisms and the evidence for implementing interventions.Semantic proximity Read ↗

The food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine activates S-phase checkpoint and apoptosis, and induces gene mutation in human lymphoblastoid TK6 cells.Semantic proximity Read ↗

Overview of biological mechanisms of human carcinogensSemantic proximity Read ↗

CANCER CHEMOPREVENTION BY NATURAL-PRODUCTS (REVIEW)Semantic proximity Read ↗

Genetic polymorphisms and modulation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-DNA adducts in human lymphocytes.Semantic proximity Read ↗

[Natural anti-mutagenic and anti-carcinogenic substances].Semantic proximity Read ↗

IARC Carcinogen UpdateSemantic proximity Read ↗

[Antimutagenic properties of food].Semantic proximity Read ↗

Molecular and genetic toxicology of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.